Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-γ-mediated signaling

Clinical Immunology

Volumn 107, Issue 3, 2003, Pages 170-177

  Heystek, H C ^a   Den Drijver, B ^b   Kapsenberg, M L ^a   Van Lier, R A W ^a   De Jong, E C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

Dendritic cells; IFN ; IFN ; IL 12; Multiple sclerosis

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; PROTEIN P70;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DEVELOPMENTAL STAGE; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; TH1 CELL;

EID: 0038541707     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00060-3     Document Type: Article

References (45)

1. Battaglia A.M., Hagmeyer K.O. Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection. Ann. Pharmacother. 34:2000;487-494.
2. Kirkwood J.M., Strawderman M.H., Ernstoff M.S., Smith T.J., Borden E.C., Blum R.H. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma the Eastern Cooperative Oncology Group Trial EST 1684 . J. Clin. Oncol. 14:1996;7-17.
3. I. Clinical results of a multicenter, randomized, double- blind, placebo-controlled trial. Neurology. 43:1993;655-661.
4. Clemens M.J., McNurlan M.A. Regulation of cell proliferation and differentiation by interferons. Biochem. J. 226:1985;345-360.
5. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr. Opin. Immunol. 12:2000;419-424.
6. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.E., Layden T.J., Perelson A.S. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 282:1998;103-107.
7. Cacciarelli T.V., Martinez O.M., Gish R.G., Villanueva J.C., Krams S.M. Immunoregulatory cytokines in chronic hepatitis C virus infection pre- and posttreatment with interferon alfa . Hepatology. 24:1996;6-9.
8. Borden E.C., Hogan T.F., Voelkel J.G. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. Cancer Res. 42:1982;4948-4953.
9. Luo Y., Chen X., Downs T.M., DeWolf W.C., O'Donnell M.A. IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guerin immunotherapy. J. Immunol. 162:1999;2399-2405.
10. Rudick R.A., Cohen J.A., Weinstock-Guttman B., Kinkel R.P., Ransohoff R.M. Management of multiple sclerosis. N. Engl. J. Med. 337:1997;1604-1611.
11. Beck J., Rondot P., Catinot L., Falcoff E., Kirchner H., Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis do cytokines trigger off exacerbations? Acta Neurol. Scand. 78:1988;318-323.
12. Karp C.L., Biron C.A., Irani D.N. Interferon beta in multiple sclerosis is IL-12 suppression the key? Immunol. Today. 21:2000;24-28.
13. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity T-T help via APC activation . J. Exp. Med. 184:1996;747-752.
14. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:1999;821-829.
15. Verhasselt V., Buelens C., Willems F., De Groote D., Haeffner-Cavaillon N., Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells evidence for a soluble CD14-dependent pathway . J. Immunol. 158:1997;2919-2925.
16. Heufler C., Koch F., Stanzl U., Topar G., Wysocka M., Trinchieri G., Enk A., Steinman R.M., Romani N., Schuler G. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol. 26:1996;659-668.
17. Snijders A., Kalinski P., Hilkens C.M., Kapsenberg M.L. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10:1998;1593-1598.
18. Trinchieri G. Interleukin-12 a cytokine at the interface of inflammation and immunity . Adv. Immunol. 70:1998;83-243.
19. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
20. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment downregulation by cytokines and bacterial products . J. Exp. Med. 182:1995;389-400.
21. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1994;1109-1118.
22. Jewett A., Gan X.H., Lebow L.T., Bonavida B. Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation. J. Clin. Immunol. 16:1996;46-54.
23. Cousens L.P., Peterson R., Hsu S., Dorner A., Altman J.D., Ahmed R., Biron C.A. Two roads diverged interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection . J. Exp. Med. 189:1999;1315-1328.
24. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D.H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:1997;825-831.
25. Rogge L., D'Ambrosio D., Biffi M., Penna G., Minetti L.J., Presky D.H., Adorini L., Sinigaglia F. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 161:1998;6567-6574.
26. McRae B.L., Semnani R.T., Hayes M.P., van Seventer G.A. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 160:1998;4298-4304.
27. Cousens L.P., Orange J.S., Su H.C., Biron C.A. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA. 94:1997;634-639.
28. Byrnes A.A., Ma X., Cuomo P., Park K., Wahl L., Wolf S.F., Zhou H., Trinchieri G., Karp C.L. Type I interferons and IL-12 convergence and cross-regulation among mediators of cellular immunity . Eur. J. Immunol. 31:2001;2026-2034.
29. Luft T., Luetjens P., Hochrein H., Toy T., Masterman K.A., Rizkalla M., Maliszewski C., Shortman K., Cebon J., Maraskovsky E. IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte- derived dendritic cells. Int. Immunol. 14:2002;367-380.
30. Hermann P., Rubio M., Nakajima T., Delespesse G., Sarfati M. IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression. J. Immunol. 161:1998;2011-2018.
31. Dayal A.S., Jensen M.A., Lledo A., Amason B.G. Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology. 45:1995;2173-2177.
32. Radvanyi L.G., Banerjee A., Weir M., Messner H. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand. J. Immunol. 50:1999;499-509.
33. Luft T., Pang K.C., Thomas E., Hertzog P., Hart D.N., Trapani J., Cebon J. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1998;1947-1953.
34. McRae B.L., Beilfuss B.A., van Seventer G.A. IFN-beta differentially regulates CD40-induced cytokine secretion by human dendritic cells. J. Immunol. 164:2000;23-28.
35. 2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood. 97:2001;3466-3469.
36. Hochrein H., O'Keeffe M., Luft T., Vandenabeele S., Grumont R.J., Maraskovsky E., Shortman K. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192:2000;823-833.
37. van Seventer J.M., Nagai T., van Seventer G.A. Interferon-beta differentially regulates expression of the IL-12 family members p35, p40, p19 and EB13 in activated human dendritic cells. J. Neuroimmunol. 133:2002;60-71.
38. Inaba K., Kitaura M., Kato T., Watanabe Y., Kawade Y., Muramatsu S. Contrasting effect of alpha/beta-1 and gamma-interferons on expression of macrophage la antigens. J. Exp. Med. 163:1986;1030-1035.
39. Alan R., Ezekowitz B., Hill M., Gordon S. Interferon alpha/beta selectively antagonises down-regulation of mannosyl-fucosyl receptors on activated macrophages by interferon gamma. Biochem. Biophys. Res. Commun. 136:1986;737-744.
40. Pace J.L., MacKay R.J., Hayes M.P. Suppressive effect of interferon-beta on development of tumoricidal activity in mouse macrophages. J. Leukoc. Biol. 41:1987;257-263.
41. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
42. Panitch H.S., Hirsch R.L., Haley A.S., Johnson K.P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. 1:1987;893-895.
43. Leonard J.P., Waldburger K.E., Goldman S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:1995;381-386.
44. Rep M.H., Schrijver H.M., van Lopik T., Hintzen R.Q., Roos M.T., Ader H.J., Polman C.H., van Lier R.A. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients. J. Neuroimmunol. 96:1999;92-100.
45. Aste-Amezaga M., Ma X., Sartori A., Trinchieri G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160:1998;5936-5944.